Stempoint Capital »

Bright Minds Biosciences shares owned by Stempoint Capital

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.6M 97k 78.04

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
BlackRock
Braidwell
MPM Oncology Impact Management
Sio Capital Management
Balyasny Asset Management
Ikarian Capital
Eventide Asset Management
Stempoint Capital
Longwood Capital Partners
State Street Corporation

View all funds holding Bright Minds Biosciences